Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2020 Filed May 6, 2020 21:17 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 1,904 | $77.67 | $147,883.68 |
DisclosureSEC source: 0001127602-20-015658 · form4.xml · nonDerivative · entry 1 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,797.106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2020 Filed May 5, 2020 20:42 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015447 · form4.xml · derivative · entry 5 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,084 Underlying: Common Stock · 1,541 shares Expires 2022-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F5 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2020 Filed May 5, 2020 20:42 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Tax withholdingCommon Stock | 529 | $77.67 | $41,087.43 |
DisclosureSEC source: 0001127602-20-015447 · form4.xml · nonDerivative · entry 2 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,560.334 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 03, 2020 Filed May 5, 2020 20:42 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
Exercise / conversionCommon Stock | 1,541 | $77.67 | $119,689.47 |
DisclosureSEC source: 0001127602-20-015447 · form4.xml · nonDerivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,089.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2020 Filed May 5, 2020 20:48 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionRestricted Stock Unit · Derivative | 875 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015451 · form4.xml · derivative · entry 5 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 875 shares Expires 2022-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F5 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022. Read SEC document |
| May 03, 2020 Filed May 5, 2020 20:48 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Tax withholdingCommon Stock | 431 | $77.67 | $33,475.77 |
DisclosureSEC source: 0001127602-20-015451 · form4.xml · nonDerivative · entry 2 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,502.972 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 03, 2020 Filed May 5, 2020 20:48 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionCommon Stock | 875 | $77.67 | $67,961.25 |
DisclosureSEC source: 0001127602-20-015451 · form4.xml · nonDerivative · entry 1 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,933.972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:35 UTC |
Chattopadhyay SanatExe V-P & Pres. MMD
|
GrantStock Option (Right to Buy) · Derivative | 84,576 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001127602-20-015439 · form4.xml · derivative · entry 2 Chattopadhyay Sanat · CIK 0001670690 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,576 Underlying: Common Stock · 84,576 shares Expires 2030-04-30 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:37 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,514 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001127602-20-015441 · form4.xml · derivative · entry 3 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,514 Underlying: Common Stock · 75,514 shares Expires 2030-04-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:38 UTC |
Davis Robert MEVP, Global Svcs & CFO
|
GrantStock Option (Right to Buy) · Derivative | 120,823 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001127602-20-015443 · form4.xml · derivative · entry 2 Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,823 Underlying: Common Stock · 120,823 shares Expires 2030-04-30 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:41 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
|
GrantStock Option (Right to Buy) · Derivative | 75,514 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001127602-20-015445 · form4.xml · derivative · entry 3 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,514 Underlying: Common Stock · 75,514 shares Expires 2030-04-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:42 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
GrantRestricted Stock Unit · Derivative | 2,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015447 · form4.xml · derivative · entry 4 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,704 Underlying: Common Stock · 2,704 shares Expires 2023-05-01 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:42 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
GrantStock Option (Right to Buy) · Derivative | 21,144 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001127602-20-015447 · form4.xml · derivative · entry 3 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,144 Underlying: Common Stock · 21,144 shares Expires 2030-04-30 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:43 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 475,740 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001127602-20-015449 · form4.xml · derivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475,740 Underlying: Common Stock · 475,740 shares Expires 2030-04-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:45 UTC |
Gerberding Julie L.EVP Strat Comm, GI Pub Policy
|
GrantStock Option (Right to Buy) · Derivative | 33,226 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001127602-20-015450 · form4.xml · derivative · entry 2 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, GI Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,226 Underlying: Common Stock · 33,226 shares Expires 2030-04-30 F1 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:48 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
GrantRestricted Stock Unit · Derivative | 2,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015451 · form4.xml · derivative · entry 4 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,704 Underlying: Common Stock · 2,704 shares Expires 2023-05-01 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:48 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
GrantStock Option (Right to Buy) · Derivative | 21,144 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001127602-20-015451 · form4.xml · derivative · entry 3 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,144 Underlying: Common Stock · 21,144 shares Expires 2030-04-30 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:49 UTC |
MIZELL STEVENEVP, Chief HR Officer
|
GrantStock Option (Right to Buy) · Derivative | 57,391 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001127602-20-015452 · form4.xml · derivative · entry 2 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,391 Underlying: Common Stock · 57,391 shares Expires 2030-04-30 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:51 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
GrantStock Option (Right to Buy) · Derivative | 57,391 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001127602-20-015454 · form4.xml · derivative · entry 3 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,391 Underlying: Common Stock · 57,391 shares Expires 2030-04-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:52 UTC |
PERLMUTTER ROGER MExe V-P & Pres, MRL
|
GrantStock Option (Right to Buy) · Derivative | 151,029 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001127602-20-015456 · form4.xml · derivative · entry 2 PERLMUTTER ROGER M · CIK 0001184228 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,029 Underlying: Common Stock · 151,029 shares Expires 2030-04-30 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:53 UTC |
Zachary JenniferEVP, General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 75,514 | $0.00 Strike: $77.67 | $0.00 |
DisclosureSEC source: 0001127602-20-015458 · form4.xml · derivative · entry 2 Zachary Jennifer · CIK 0001737231 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,514 Underlying: Common Stock · 75,514 shares Expires 2030-04-30 F2 · derivative.exercise_date: The option vests and becomes exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:29 UTC |
Coe Mary EllenDirector
|
GrantPhantom Stock · Derivative | 422.407 | $76.94 | $32,499.99 |
DisclosureSEC source: 0001127602-20-012711 · form4.xml · derivative · entry 2 Coe Mary Ellen · CIK 0001691304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,037.871 Underlying: Common Stock · 422.407 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:33 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 227.45 | $76.94 | $17,500.00 |
DisclosureSEC source: 0001127602-20-012716 · form4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,996.727 Underlying: Common Stock · 227.45 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:35 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 389.9142 | $76.94 | $30,000.00 |
DisclosureSEC source: 0001127602-20-012719 · form4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,596.2422 Underlying: Common Stock · 389.9142 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:37 UTC |
Seidman Christine EDirector
|
GrantPhantom Stock · Derivative | 36.3361 | $76.94 | $2,795.70 |
DisclosureSEC source: 0001127602-20-012723 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150.1374 Underlying: Common Stock · 36.3361 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:43 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 389.9142 | $76.94 | $30,000.00 |
DisclosureSEC source: 0001127602-20-012733 · form4.xml · derivative · entry 2 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,485.8692 Underlying: Common Stock · 389.9142 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:49 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 389.9142 | $76.94 | $30,000.00 |
DisclosureSEC source: 0001127602-20-012751 · form4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,567.3772 Underlying: Common Stock · 389.9142 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 21:24 UTC |
Seidman Christine EDirector
|
GrantPhantom Stock · Derivative | 113.8013 | $69.92 | $7,956.99 |
DisclosureSEC source: 0001127602-20-011293 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113.8013 Underlying: Common Stock · 113.8013 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 21:25 UTC |
Warden Kathy JDirector
|
GrantPhantom Stock · Derivative | 113.8013 | $69.92 | $7,956.99 |
DisclosureSEC source: 0001127602-20-011294 · form4.xml · derivative · entry 2 Warden Kathy J · CIK 0001559112 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113.8013 Underlying: Common Stock · 113.8013 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:16 UTC |
Davis Robert MEVP, Global Svcs & CFO
|
GrantCommon Stock | 33,396 | $76.56 | $2,556,797.76 |
DisclosureSEC source: 0001127602-20-009122 · form4.xml · nonDerivative · entry 1 Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,055.757 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:19 UTC |
Chattopadhyay SanatExe V-P & Pres. MMD
|
GrantCommon Stock | 15,785 | $76.56 | $1,208,499.60 |
DisclosureSEC source: 0001127602-20-009126 · form4.xml · nonDerivative · entry 1 Chattopadhyay Sanat · CIK 0001670690 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,632.08 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:20 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
GrantCommon Stock | 4,905 | $76.56 | $375,526.80 |
DisclosureSEC source: 0001127602-20-009129 · form4.xml · nonDerivative · entry 1 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,297.991 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:24 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
|
GrantCommon Stock | 14,374 | $76.56 | $1,100,473.44 |
DisclosureSEC source: 0001127602-20-009135 · form4.xml · nonDerivative · entry 1 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,856.868 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:27 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
GrantCommon Stock | 1,659 | $76.56 | $127,013.04 |
DisclosureSEC source: 0001127602-20-009142 · form4.xml · nonDerivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,513.879 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:29 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GrantCommon Stock | 119,291 | $76.56 | $9,132,918.96 |
DisclosureSEC source: 0001127602-20-009146 · form4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 783,619.063 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:30 UTC |
Gerberding Julie L.EVP Strat Comm, GI Pub Policy
|
GrantCommon Stock | 7,371 | $76.56 | $564,323.76 |
DisclosureSEC source: 0001127602-20-009149 · form4.xml · nonDerivative · entry 1 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, GI Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,409.366 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:34 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
GrantCommon Stock | 4,269 | $76.56 | $326,834.64 |
DisclosureSEC source: 0001127602-20-009154 · form4.xml · nonDerivative · entry 1 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,058.972 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:35 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
GrantCommon Stock | 3,328 | $76.56 | $254,791.68 |
DisclosureSEC source: 0001127602-20-009156 · form4.xml · nonDerivative · entry 1 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,908.399 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:39 UTC |
PERLMUTTER ROGER MExe V-P & Pres, MRL
|
GrantCommon Stock | 35,049 | $76.56 | $2,683,351.44 |
DisclosureSEC source: 0001127602-20-009162 · form4.xml · nonDerivative · entry 1 PERLMUTTER ROGER M · CIK 0001184228 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,428.496 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/17. Performance shares were paid out at 137 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2019. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 22:15 UTC |
Gerberding Julie L.EVP Strat Comm, GI Pub Policy
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 33,012 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001127602-20-001661 · form4.xml · derivative · entry 5 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, GI Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,012 shares Expires 2024-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option became exercisable in equal installments on 5/2/2015, 5/2/2016 and 5/2/2017. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 22:15 UTC |
Gerberding Julie L.EVP Strat Comm, GI Pub Policy
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 49,536 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001127602-20-001661 · form4.xml · derivative · entry 4 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, GI Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,536 shares Expires 2025-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in equal installments on 5/1/2016, 5/1/2017 and 5/1/2018. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 22:15 UTC |
Gerberding Julie L.EVP Strat Comm, GI Pub Policy
|
SaleCommon Stock | 102,073 | $89.34 | $9,118,864.98 |
DisclosureSEC source: 0001127602-20-001661 · form4.xml · nonDerivative · entry 3 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, GI Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,038.366 F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.04 to $89.61, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 22:15 UTC |
Gerberding Julie L.EVP Strat Comm, GI Pub Policy
|
Exercise / conversionCommon Stock | 33,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-001661 · form4.xml · nonDerivative · entry 2 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, GI Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,111.366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 22:15 UTC |
Gerberding Julie L.EVP Strat Comm, GI Pub Policy
|
Exercise / conversionCommon Stock | 49,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-001661 · form4.xml · nonDerivative · entry 1 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, GI Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,099.366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:47 UTC |
Coe Mary EllenDirector
|
GrantPhantom Stock · Derivative | 343.5954 | $90.95 | $31,250.00 |
DisclosureSEC source: 0001127602-20-000762 · form4.xml · derivative · entry 2 Coe Mary Ellen · CIK 0001691304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,593.0924 Underlying: Common Stock · 343.5954 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:51 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 185.5415 | $90.95 | $16,875.00 |
DisclosureSEC source: 0001127602-20-000772 · form4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,307.1525 Underlying: Common Stock · 185.5415 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:56 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 316.1078 | $90.95 | $28,750.00 |
DisclosureSEC source: 0001127602-20-000780 · form4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,612.1898 Underlying: Common Stock · 316.1078 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 22:04 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 316.1078 | $90.95 | $28,750.00 |
DisclosureSEC source: 0001127602-20-000798 · form4.xml · derivative · entry 2 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,468.3828 Underlying: Common Stock · 316.1078 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 22:10 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 316.1078 | $90.95 | $28,750.00 |
DisclosureSEC source: 0001127602-20-000814 · form4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,542.4948 Underlying: Common Stock · 316.1078 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| November 12, 2019 Filed Feb 13, 2020 22:18 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GiftCommon Stock | 118,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005334 · form5.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 664,328.063 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.